Ginkgo Bioworks buys North Carolina startup's gene therapy platform
The future of a North Carolina-based gene therapy company founded by a Duke University professor is unclear now that it has sold its main platform. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - April 6, 2023 Category: Pharmaceuticals Authors: Zac Ezzone Source Type: news
Home Showcase: Architecture as art in Ashmont Hill
It’s perhaps fitting that 3 Ocean Street in Dorchester’s Ashmont Hill neighborhood is home to one of the largest ginkgo biloba trees in Boston. The tree is a symbol for resilience in Asia and is known as a hardy survivor, much like its current real estate steward. It might not be the most ornate…#oceanstreet #ashmonthill #boston #dorchester #historic #crown #matthewdiozzi #compass #bedrooms #appraisalprostons (Source: Reuters: Health)
Source: Reuters: Health - March 24, 2023 Category: Consumer Health News Source Type: news
Zymergen's connections to SVB tie up some Ginkgo Bioworks cash
Ginkgo inherited the relationship from last year's acquisition of synthetic biology flameout Zymergen. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 13, 2023 Category: Pharmaceuticals Authors: Rowan Walrath Source Type: news
Ginkgo Bioworks' biggest acquisition has $74M tied up in SVB
Ginkgo has $74 million in the recently failed Silicon Valley Bank, all of it inherited from an acquisition last year on which it spent $300 million. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - March 13, 2023 Category: American Health Authors: Rowan Walrath Source Type: news
Microbial Immunotherapy Company Prokarium Raises $30M On Heels Of Ginkgo Bioworks Partnership
the next time you think Salmonella, think Prokarium. These bacteria may cause food poisoning in one form, but engineered the right way can become living medicine — turning not fuel into fire but fire into fuel. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - February 9, 2023 Category: Pharmaceuticals Authors: John Cumbers, Senior Contributor Tags: Manufacturing /manufacturing Business /business Innovation /innovation Healthcare /healthcare Source Type: news
Ginkgo Has Hired A New Head Of Biopharma To Disrupt The Gene And Cell Therapies Market
Cell therapies save lives but can cost millions of dollars because of how slow and inefficient pharma R&D is. What if cell engineering was outsourced to synbio companies like Ginkgo that specialize in programming biology? This could be a game changer. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 15, 2022 Category: Pharmaceuticals Authors: John Cumbers, Senior Contributor Tags: Manufacturing /manufacturing Business /business Innovation /innovation Healthcare /healthcare Source Type: news
Herbals, Yoga, Ginkgo: What Alternative Treatments Help Fight Heart Failure?
MONDAY, Dec. 12, 2022 -- It’s tempting to follow the latest trend when it comes to health care, but for patients who live with heart failure, some alternative treatments could have serious consequences.
To address the issue, the American... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 12, 2022 Category: General Medicine Source Type: news
Down 76% This Year, Is This Growth Stock Now a Screaming Buy?
When shares of innovative growth stocks like Ginkgo Bioworks (DNA -0.28%) plummet, cunning investors know that there could be opportunity in the air. So even if a company like Ginkgo is down by more than 76% in 2022, it's a good time to take a closer look. In fact, there are a few reasons to…#ginkgobioworks #cronos #cronosgroup #ginkgo (Source: Reuters: Health)
Source: Reuters: Health - December 6, 2022 Category: Consumer Health News Source Type: news
Ginkgo Bioworks offers former West Sac Bayer employees stock options
(Source: Reuters: Health)
Source: Reuters: Health - December 4, 2022 Category: Consumer Health News Source Type: news
Ginkgo Bioworks raising $100 million, partly to pay for acquisition of Bayer's Sacramento facilities
Boston-based Ginkgo Bioworks Holdings Inc. said it plans to sell $100 million of its stock in a public offering in order to pay for its acquisition of Bayer assets in California. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - November 16, 2022 Category: American Health Authors: Mark Anderson Source Type: news
Health Officials Are Now Tracking COVID-19 Variants at Airports
Travelers are both the conduit and the canary in the coal mine for new COVID-19 variants, and U.S. health officials are trying to use those realities to keep ahead of variants coming into the country.
At four U.S. airports—John F. Kennedy in New York, Newark in New Jersey, San Francisco International, and Atlanta Hartsfield—the Centers for Disease Control and Prevention (CDC) is partnering with private companies XpressCheck and Concentric by Ginkgo to test incoming passengers for COVID-19. (Washington Dulles is expected to join the program in November.) The testing gives the CDC a heads up on which variants are...
Source: TIME: Health - November 3, 2022 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news
Exclusive: Ginkgo CEO — Emeryville site could be synthetic biology incubator
Zymergen signed a 12-year lease for the biotech landmark site — once the headquarters of Chiron Corp. — and mostly completed renovations but never moved in before completing the company's sale this month to Ginkgo. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - October 28, 2022 Category: American Health Authors: Ron Leuty Source Type: news
The Petri Dish: Biogen SVP makes leap to Nimbus, Ginkgo partners with Saudi government
Ginkgo Bioworks is bringing its public health business to Saudi Arabia, where it will work with the Sauti government's investment arm to "add another node to a global network of pathogen monitoring infrastructure." (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - October 27, 2022 Category: Biotechnology Authors: Rowan Walrath Source Type: news
After Ginkgo merger wraps up, 110 job cuts planned at synthetic biology company Zymergen
The merger was completed last week, but the job cuts will start in December. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - October 26, 2022 Category: American Health Authors: Ron Leuty Source Type: news
Merck hires local synbio player for cell manufacturing
Merck& Company Inc. is hiring synthetic biology firm Ginkgo Bioworks Holdings Inc. to engineer a crucial component of some of its medicines. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - October 11, 2022 Category: Pharmaceuticals Authors: Rowan Walrath Source Type: news
